Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D07AXA
|
||||
Former ID |
DIB007833
|
||||
Drug Name |
Fatty acid amide hydrolase inhibitors
|
||||
Synonyms |
Fatty acid amide hydrolase inhibitors (pain/inflammation); FAAH inhibitors (pain/inflammation), Amgen; Fatty acid amide hydrolase inhibitors (pain/inflammation), Amgen
|
||||
Indication | Inflammatory disease [ICD9: 140-229, 147, 173, 573.3, 710-719; ICD10:C11, C44, K75.9, M00-M25] | Investigative | [552100] | ||
Company |
Amgen Inc
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
n1(c(=O)n(c2c1cccc2)CC)C1CN(c2nccc(n2)c2cc3c(o2)cccc3)C<br />CC1
|
||||
Target and Pathway | |||||
Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [543418] | |
BioCyc Pathway | Anandamide degradation | ||||
KEGG Pathway | Retrograde endocannabinoid signaling | ||||
PANTHER Pathway | Anandamide degradation | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.